Atovaquone for Treatment of COVID-19: A Prospective Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Mamta K. Jain, James A. de Lemos, Darren K. McGuire, Colby Ayers, Jennifer L. Eiston, Claudia L. Sanchez, Dena Kamel, Jessica A. Meisner, Emilia V. Thomas, Anita A. Hegde, Satish Mocherla, Joslyn K. Strebe, Xilong Li, Noelle S. Williams, Chao Xing, Mahmoud S. Ahmed, Ping Wang, Hesham A. Sadek, John W. Schoggins
doi: https://doi.org/10.1101/2022.05.24.22275411

Article usage

Article usage: May 2022 to August 2025

AbstractFullPdf
May 2022608875
Jun 2022388577
Jul 2022161522
Aug 2022161516
Sep 202212064
Oct 202211313
Nov 202266011
Dec 202267514
Jan 202337418
Feb 202340122
Mar 20234957
Apr 202342411
May 20232927
Jun 202320513
Jul 20231814
Aug 2023311211
Sep 202324510
Oct 20231355
Nov 202338198
Dec 20233817
Jan 20241126
Feb 20241879
Mar 202428315
Apr 202411411
May 20241038
Jun 20241638
Jul 202411521
Aug 20247614
Sep 202421715
Oct 20241278
Nov 202411110
Dec 20246114
Jan 202511421
Feb 2025141829
Mar 2025432619
Apr 2025211023
May 202530716
Jun 2025341415
Jul 2025101310
Aug 2025001
Back to top
Posted May 25, 2022.
Download PDF
Data/Code
Email
Atovaquone for Treatment of COVID-19: A Prospective Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Mamta K. Jain, James A. de Lemos, Darren K. McGuire, Colby Ayers, Jennifer L. Eiston, Claudia L. Sanchez, Dena Kamel, Jessica A. Meisner, Emilia V. Thomas, Anita A. Hegde, Satish Mocherla, Joslyn K. Strebe, Xilong Li, Noelle S. Williams, Chao Xing, Mahmoud S. Ahmed, Ping Wang, Hesham A. Sadek, John W. Schoggins
medRxiv 2022.05.24.22275411; doi: https://doi.org/10.1101/2022.05.24.22275411
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area